Will Hahn Email & Phone Number

Sacramento, California, US

• As the Director of Strategy and Business Development, I design and execute enterprise-wide initiatives and market-oriented projects targeting growth opportunities for outpatient and inpatient services, and the Sutter.
• Appointed the Sutter-wide lead for bundled payment programs, including clinical care transformation efforts. On-target to realize $22M in net savings over 5 years.
• Leading role in driving growth through transformational initiatives, clinical service lines, strategic partnerships, and business development deals.

Mountain View, CA, US

• I led cross-functional teams on enterprise-wide initiatives and divisionally-oriented projects improving clinical outcomes, enhancing the experience of patients, reducing the total cost of care, expanding services and.
• Nominated for the Leadership Academy, Sutter Health's most prestigious professional development program
• Led design and implementation of an innovative behavioral health program integrated with primary care and delivering $120M in projected savings across the region
• Led Revenue Cycle enhancement efforts, generating over $6.7M in incremental revenue per annum
• Managed lean implementation across 37 departments (i.e., daily management system, A3 thinking, standard work, tiered metrics, and visual management)
• Led strategic partnership with local FQHCs resulting in over $2.0M of community benefit fundingDuring my tenure in this role, the organization became a state-recognized leader in clinical quality and patient.

Despite a 40% reduction in total revenue due to the state-wide elimination of Medi-Cal's optional benefits, my team and I transformed this Federally Qualified Health Center (FQHC) through innovation and operational improvements. We grew market share by 45%, improved the value of patient care (better quality at a lower cost), delivered record profitability.

Washington, DC, US

Worked directly with 30 member Board of Directors and Senior Executive Team to lead strategic planning and programmatic growth of a renowned professional medical society. Grew revenues from $65M to $95M over 2.5 years in new and existing markets, identified over $4.5M in annual savings, and increased staff from 200 to over 300 FTEs. Developed five-year.

• Healthcare strategic management consulting, focused on business strategy formulation, clinical transformation, and performance improvement engagements.
• Helped establish a management strategy consulting practice for the healthcare division of a Fortune 500 company. My responsibilities included profit/loss, client & project management, recruitment, and daily operations.
• Conducted the process redesign for an EPIC implementation at Kaiser Permanente's Southern California region, personally identifying over $700M in future benefits via performance optimization. Worked with the senior.
• Led a strategic planning engagement for a community hospital, working with the CEO and executive team to analyze business performance and develop strategic objectives with tactical plans for mission critical.
• Generated over $500K in client sales through numerous work opportunities identified and responses to RFI and RFP.

Worldwide, OO

• Strategy & Operations, healthcare practice
• Led the process redesign for HealthSouth's Surgery Division (over $1B in annual net revenue) as part of a turnaround effort resulting in the client successfully being relisted on the NYSE. Redesigned business processes.
• Led strategic planning for 5 hospital service lines at the University of Kentucky's Medical Center (Digestive Health, OB/Newborn, Ophthalmology, Endocrinology/Nutrition, and Infectious Disease) with best practices and.
• Responsible for development of business plans for 15 separate hospital service lines, including financial analysis and tactical work steps. Worked with executive and physician leadership to reach consensus and board.

• Healthcare strategy consulting firm serving the healthcare vertical. Responsibilities and accomplishments included:
• Led the analysis of market trends, profit potential and inpatient/outpatient utilization growth for six major hospital service lines as part of a strategic planning engagement with Hospital Corporation of America/HCA..
• Developed a comprehensive corporate strategy for a leading Third Party Administrator (TPA), managing all aspects of the business planning process from budget allocation to the creation of key performance metrics.
• Led sales force redesign for the nations leading wholesale PPO network organization by aligning internal capabilities to new market opportunities, redefining sales roles and minimizing channel conflict.
• Managed new market development plan and business impact forecast through customer segmentation within corporate strategic planning process for the nation’s largest health care provider network.

• Coordinated a cross-functional team of 10 people (consulting, finance, marketing, sales, technical design) to develop a business plan, enabling IBM brands to pursue a $20B IT opportunity in the health care market.
• Designed a $2.5B value capture model for data management solutions by conducting market sizing, customer segmentation, portfolio analysis, environmental and competitive analysis.
• Identified and defined a high-revenue growth opportunity in the knowledge management domain, valued at $700M. Developed a global service recommendation to demonstrate IBM’s value of IT solutions for sales training and.

• Biotech firm specializing in the discovery and development of protein-based drug therapies via directed evolution technology. This firm has since been acquired by Eli Lilly.
• Worked within a cross-functional team to develop second generation medications for FDA approved drugs, designing and conducting research using directed evolution for protein-based drug therapies (antibodies and.
• Participated in development of Numax, reducing production costs 1000% to address new target markets (infants and geriatrics) with potential annual revenues of $900M.
• Increased accuracy and consistency of a key quantitation technique, reducing costs by 20% and time by 200%. Won approval from senior management for company wide integration.

• Biotech firm focused on discovery and development of antibody therapies via phage display technologies. This firm has since been acquired by Alexion Pharmaceuticals.
• Generated antibody libraries for immunotherapy targets, the primary interest in a $40 million acquisition negotiated with Alexion Pharmaceuticals. Designed and promoted a directed cellular development system for.

Mba, Entrepreneurship, Health Industry Management, Marketing, And Strategy

Bs, Biochemistry & Cellular Biology